On April 9, 2024, Biotricity, Inc. closed the transaction. The company announced that it has issued 110 shares of Series B Convertible Preferred Stock at an issue price of $9,090.91 per share for the gross proceeds of $1,000,000.1 in the second and final tranche. The minimum investment from an outsider is $1,000,000 and included participation from single investor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.295 USD | -1.15% | -10.69% | +12.61% |
Apr. 26 | Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro | CI |
Apr. 19 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
+12.61% | 12.4M | |
-9.00% | 160M | |
-14.17% | 82.84M | |
+30.43% | 60.06M |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. announced that it has received $2 million in funding